Watch sustainability champions reveal key solutions, innovations accelerating India's SDGs at ‘The Sustainability 100+ Dialogues 2021’-Haryana Roundtable on March 5 at 12pm
you are here: HomeNewsIndia

Coronavirus update: India reports 11,666 new cases; recovery rate at 96.94%

The total infections have mounted to 1,07,01,193. The death toll increased to 1,53,847 with 123 daily new fatalities, the data updated at 8 am showed.

January 28, 2021 / 10:35 AM IST
Source: Reuters

Source: Reuters

India's COVID-19 tally of cases crossed 1.07 crore with11,666 new coronavirus infections being reported in a day,while the number of people who have recuperated from the disease has surged to 1,03,73,606 pushing the national recovery rate to 96.94 percent,accordingto the Union Health Ministry data updated on Thursday.

The total infections have mounted to 1,07,01,193. The death toll increased to 1,53,847 with 123 daily new fatalities, the data updated at 8 am showed.

The number of people who have recuperated from the disease surged to 1,03,73,606 pushing the national COVID-19 recovery rate to 96.94 percent,while the COVID-19 case fatality rate stands at 1.44 percent.

The COVID-19 active cases remained below 2 lakh for the ninth consecutive day.

There are 1,73,740 active coronavirus infections in the country which comprises 1.62 percent of the total caseload, the data stated.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

India's COVID-19 tally had crossed the 20-lakh mark on August 7,30 lakh on August 23, 40 lakh on September 5 and50 lakh onSeptember 16. It went past 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, 90 lakh onNovember 20 and surpassed the one-crore mark on December 19.

According to the ICMR, 19,43,38,773 samples have been tested up to January 27 with 7,25,653 samples being tested on Wednesday.
PTI
first published: Jan 28, 2021 10:27 am

stay updated

Get Daily News on your Browser
Sections